Lexagene Holdings (TSXV:LXG.H) Dividends per Share : C$0.00 (TTM As of Nov. 2022)

View and export this data going back to 2007. Start your Free Trial

What is Lexagene Holdings Dividends per Share?

Lexagene Holdings's dividends per share for the three months ended in Nov. 2022 was C$0.00. Its dividends per share for the trailing twelve months (TTM) ended in Nov. 2022 was C$0.00. Its Dividend Payout Ratio for the three months ended in Nov. 2022 was 0.00. As of today, Lexagene Holdings's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.

Lexagene Holdings Dividends per Share Historical Data

The historical data trend for Lexagene Holdings's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lexagene Holdings Dividends per Share Chart

Lexagene Holdings Annual Data

Trend

Mar13

Mar14

Mar15

Feb16

Feb17

Feb18

Feb19

Feb20

Feb21

Feb22

Dividends per Share

Get a 7-Day Free Trial

Lexagene Holdings Quarterly Data
	Feb18	May18	Aug18	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22
Dividends per Share	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Lexagene Holdings's Dividends per Share

For the Medical Devices subindustry, Lexagene Holdings's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lexagene Holdings's Dividend Yield % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lexagene Holdings's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Lexagene Holdings's Dividend Yield % falls into.

Lexagene Holdings Dividends per Share Calculation

Dividends paid to per common share.

Lexagene Holdings (TSXV:LXG.H) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Lexagene Holdings's Dividend Payout Ratio for the quarter that ended in Nov. 2022 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Nov. 2022 )	/	EPS without NRI (Q: Nov. 2022 )
	=	0	/	-0.013
	=	N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

Lexagene Holdings Dividends per Share Related Terms

Thank you for viewing the detailed overview of Lexagene Holdings's Dividends per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Lexagene Holdings (TSXV:LXG.H) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lexagene Holdings Inc (TSXV:LXG.H) » Definitions » Dividends per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

500 Cummings Center, Suite 4550, Beverly, MA, USA, 01915

Website

https://www.lexagene.com

Lexagene Holdings Inc is a molecular diagnostics company that develops molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The MiQLab system delivers sensitivity, specificity, and breadth of detection and can return results in approximately two hours. The unique open-access feature is designed for custom testing so that end-users can load their own real-time PCR assays onto the instrument to target any genetic target of interest.

Lexagene Holdings (TSXV:LXG.H) Headlines

No Headlines